| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 17, 2022Virtual Press Office and PR Newswire: General Trade show news
LogicBio Therapeutics, Inc. (Nasdaq: LOGC), a clinical-stage genetic medicine company, today announced that president and chief executive officer, Frederic Chereau, will present a company overview...
-
May 17, 2022Virtual Press Office and PR Newswire: General Trade show news
Preclinical data supports potential of P-ckit-ALLO1 as a less toxic preconditioning agent for hematopoietic stem cell (HSC) transplants P-ckit-ALLO1 eliminates >95% of hematopoietic stem and...
-
May 17, 2022Virtual Press Office and PR Newswire: General Trade show news
McCormick & Company, Incorporated (NYSE: MKC), a global leader in flavor, will be participating in the 2022 Deutsche Bank dbAccess Global Consumer Conference at 10:30 a.m. CEST / 4:30 a.m. EDT, on...
-
May 17, 2022Virtual Press Office and PR Newswire: General Trade show news
Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), a late-stage, oncology-focused drug development company, marks 'DIPG Awareness Day' by recognizing the tireless work of global researchers in...
-
May 17, 2022Virtual Press Office and PR Newswire: General Trade show news
Next-generation cytoDRiVE platform enables precise control of IL12, IL23, IL2, and IFNα in genetically modified T-cells CAMBRIDGE, Mass., May 17, 2022 /PRNewswire/ -- Obsidian Therapeutics, Inc.,...
